← All trials
NCT06360874
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 9, 2024
- Primary completion
- Dec 31, 2024
- Completion date
- Feb 28, 2025
- First posted
- Apr 11, 2024
- Last posted
- May 30, 2024
- Enrollment
- 104
- Arms / groups
- 10 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
- Huazhong University of Science and TechnologyOfficial
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.